Incyte Investigative Site
				
				Dallas, Texas 75390
We've found
        1 trials
        at this facility
      	
	Graft-versus-host Disease (GVHD) Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	